From Chinese Innovation to Global Empowerment: Vivolight Medical’s Acceleration in Global Expansion at Arab Health 2025

Vivolight Medical’s at Arab Health 2025: Illuminating a New Era of Global Cooperation in the Year of the Snake

From January 27 to January 30, 2025, Vivolight Medical made a dazzling appearance at the global medical technology event—Arab Health 2025, showcasing China’s medical technology innovations and demonstrating the strength of Chinese intelligent manufacturing to the world.

As the second-largest medical device exhibition globally and the most influential medical event in the Middle East, Arab Health 2025 attracted over 4,000 exhibitors from more than 180 countries and 100,000+ professional attendees. The event covered various fields such as medical devices, diagnostic imaging, and smart healthcare, providing a highly efficient platform for global industry collaboration. With its high-precision imaging products, advanced technological applications, and outstanding clinical performance, Vivolight Medical became one of the highlights of the exhibition.

Innovative Products Empowering Precision Medicine

As a leading Chinese company specializing in minimally invasive laser-based diagnostic and therapeutic devices, Vivolight Medical presented a lineup of self-developed products, including the Vivolight’s Multimodal P80 OCT Imaging System, Projection Vein Finder, and Vglasses Vessel Navigation Glasses.

Vivolight’s Multimodal P80 OCT Imaging System: A Revolutionary Advancement in Coronary Diagnosis

The world’s first coronary OCT system integrating multimodal diagnostic functions, built on a micron-level high-resolution imaging platform, featuring three core technologies:

• Index of Plaque Attenuation (IPA):Quantifies plaque lipid composition and stability, aiding in the identification of vulnerable plaques.
• Virtual Flow Ratio(OCT-FFR): Simulates coronary blood flow function using OCT imaging data, replacing traditional pressure wire measurements.
• Intelligent Calcium Assessment (ICA):AI-driven analysis automatically detects calcified lesions and optimizes PCI intervention strategies.

A single OCT pullback scan provides multi-dimensional vascular data, including structural, functional, and compositional insights, minimizing the need for multiple devices, significantly reducing procedure time and material costs, and enhancing precision treatment of coronary artery diseas

Vivolight’s Projection Vein Finder: "Vein Mapping for Precise Venipuncture"：

Vivolight Medical showcased two models,Vivolight’s vein finer V800F and V800P, which remained highlights of the exhibition. Utilizing advanced near-infrared (NIR) light technology, these devices clearly visualize veins with an enhanced imaging depth of up to 10mm beneath the skin and a resolution of 0.5mm. They support real-time dynamic vein tracking, significantly improving the accuracy of venipuncture for medical professionals.

Thanks to its portability and high imaging accuracy, this device has become an essential tool for hospitals, clinics, and emergency scenarios. Since entering the global market in 2013, Vivolight Medical’s vein finders have been deployed in over 90 countries and regions, serving millions of patients in neonatology, oncology, and geriatrics.

Vglasses Vessel Navigation Glasses: A Breakthrough in Wearable Medical Technology

Vivolight Medical also introduced Vglasses, an innovative wearable medical device integrating Augmented Reality (AR) and infrared imaging. These smart glasses allow medical professionals to view real-time vein mapping while wearing them, improving the accuracy and success rate of venipuncture.

Designed for ergonomic comfort and all-day wear, Vglasses is particularly useful for hands-free procedures such as varicose vein marking. With high-definition real-time imaging capabilities, the device clearly displays blood flow conditions, helping practitioners accurately assess vascular status. Due to its convenience and efficiency, Vglasses attracted significant attention and became a hot topic of discussion at the exhibition.

Expanding Global Markets Through In-Depth Engagement & Leading Future Trends with Innovation

During Arab Health 2025, Vivolight Medical not only showcased its cutting-edge technologies but also engaged in in-depth discussions with international medical institutions, distributors, and potential partners. These face-to-face exchanges provided valuable insights into various market demands and localized product adaptation, laying a solid foundation for future international collaborations.

Rooted in China with a global vision, Vivolight Medical has been expanding internationally since 2013. Today, its products are successfully sold in over 90 countries and regions, and the company has established strong strategic partnerships with numerous global medical device enterprises. With its growing international presence, Vivolight Medical is committed to working with the global medical industry to advance precision medicine, bringing innovative technologies to benefit more patients worldwide.

In the fast-evolving medical industry, continuous innovation remains the driving force for corporate growth. In the new year, Vivolight Medical will seize the opportunities presented by international exhibitions, drive forward with technological innovation, and continue expanding its global footprint. The company is dedicated to showcasing the brilliance of China’s independent medical innovations and making a significant impact on the global healthcare industry!